Raab & Moskowitz Asset Management LLC
Position in ROIV — Roivant Sciences Ltd.
CIK 1616664
Chatham, NJ
Position in ROIV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$389,290
+$84,590 QoQ
Shares Held
11,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#305
of 494 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Raab & Moskowitz Asset Management LLC holds $1,481,215 across 3 Biotechnology names. ROIV ranks #2 (26.3% of the industry book) .
All Filings in ROIV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $389,290 | 11,000 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $304,700 | 11,000 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $238,700 | 11,000 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $166,430 | 11,000 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $123,970 | 11,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $110,990 | 11,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $130,130 | 11,000 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $126,940 | 11,000 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||